InnoCan Pharma Corporation (INNPF)
OTCMKTS · Delayed Price · Currency is USD
13.08
+0.55 (4.39%)
At close: Oct 3, 2025
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of $86.58 million as of October 7, 2025. Its market cap has increased by 71.64% in one year.
Market Cap
86.58M
Enterprise Value
83.28M
Revenue
28.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.08
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 800.36K to 86.58M, an increase of 10,717.30%. That is a compound annual growth rate of 117.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 86.58M | 106.73% |
| Dec 31, 2024 | 41.88M | -33.43% |
| Dec 29, 2023 | 62.91M | 58.58% |
| Dec 30, 2022 | 39.67M | -74.75% |
| Dec 31, 2021 | 157.09M | 220.33% |
| Dec 31, 2020 | 49.04M | 176.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |